The impact of drug metabolizing enzyme polymorphisms on outcomes after antenatal corticosteroid use

American Journal of Obstetrics and Gynecology

Volumn 206, Issue 5, 2012, Pages 447.e17-447.e24

  Haas, David M ^a   Lehmann, Amalia S ^a   Skaar, Todd ^a   Philips, Santosh ^a   McCormick, Catherine L ^a   Beagle, Kyle ^a   Hebbring, Scott J ^b   Dantzer, Jessica ^a   Li, Lang ^a   Jung, Jeesun ^a  

^a INDIANA UNIVERSITY   (United States)

^b MAYO CLINIC   (United States)

Author keywords

betamethasone; neonatal respiratory distress syndrome; pharmacogenetics; preterm birth

Indexed keywords

BETAMETHASONE; DRUG METABOLIZING ENZYME;

ADULT; CORTICOSTEROID THERAPY; DNA ISOLATION; ENZYME POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; PREMATURE LABOR; PRENATAL PERIOD; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84862803948     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2012.02.016     Document Type: Article

References (31)

1. American College of ObstetriciansGynecologists ACOG practice bulletin no. 43 Management of preterm labor, May 2003 Obstet Gynecol 101 2003 1039 1047
2. W.P. Frisbie, D. Forbes, S.G. Pullum Compromised birth outcomes and infant mortality among racial and ethnic groups Demography 33 1996 469 481
3. W.P. Frisbie, S.E. Song, D.A. Powers, J.A. Street The increasing racial disparity in infant mortality: respiratory distress syndrome and other causes Demography 41 2004 773 800
4. V. Kavvadia, A. Greenough, G. Dimitriou, R. Hooper Influence of ethnic origin on respiratory distress syndrome in very premature infants Arch Dis Child Fetal Neonatal Ed 78 1998 F25 F28
5. M.H. Ensom, T.K. Chang, P. Patel Pharmacogenetics: the therapeutic drug monitoring of the future? Clin Pharmacokinet 40 2001 783 802
6. S.A. Scott, K. Sangkuhl, E.E. Gardner Clinical pharmacogenetics implementation consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy Clin Pharmacol Ther 90 2011 328 332
7. D. Grossniklaus Testing of VKORC1 and CYP2C9 alleles to guide warfarin dosing Test category: pharmacogenomic (treatment) PLoS Curr 2 2010
8. S. Crettol, J.P. Venetz, M. Fontana, J.D. Aubert, M. Pascual, C.B. Eap CYP3A7, CYP3A5, CYP3A4, and ABCB1 genetic polymorphisms, cyclosporine concentration, and dose requirement in transplant recipients Ther Drug Monit 30 2008 689 699
9. M.D. Perloff, L.L. von Moltke, M.M. Cotreau, D.J. Greenblatt Unchanged cytochrome P450 3A (CYP3A) expression and metabolism of midazolam, triazolam, and dexamethasone in mdr(-/-) mouse liver microsomes Biochem Pharmacol 57 1999 1227 1232
10. G.A. Hawkins, R. Lazarus, R.S. Smith The glucocorticoid receptor heterocomplex gene STIP1 is associated with improved lung function in asthmatic subjects treated with inhaled corticosteroids J Allergy Clin Immunol 123 2009 1376 1383 e7
11. K.G. Tantisira, S. Lake, E.S. Silverman Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids Hum Mol Genet 13 2004 1353 1359
12. S.T. Weiss, S.L. Lake, E.S. Silverman Asthma steroid pharmacogenetics: a study strategy to identify replicated treatment responses Proc Am Thorac Soc 1 2004 364 367
13. B.J. Stoll, N.I. Hansen, E.F. Bell Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network Pediatrics 126 2010 443 456
14. A.S. Lehmann, D.M. Haas, C.L. McCormick, T.C. Skaar, J.L. Renbarger Collection of human genomic DNA from neonates: a comparison between umbilical cord blood and buccal swabs Am J Obstet Gynecol 204 2011 362e1 362e6
15. B.A. Raby, K. Van Steen, J. Lasky-Su Importin-13 genetic variation is associated with improved airway responsiveness in childhood asthma Respir Res 10 2009 67
16. K. Tantisira, S. Weiss, K. Tantisira, S. Weiss The pharmacogenetics of asthma treatment Curr Allergy Asthma Rep 9 2009 10 17
17. J.K. Lamba, Y.S. Lin, E.G. Schuetz, K.E. Thummel Genetic contribution to variable human CYP3A-mediated metabolism Adv Drug Deliv Rev 54 2002 1271 1294
18. S. Cholerton, A.K. Daly, J.R. Idle The role of individual human cytochromes P450 in drug metabolism and clinical response Trends Pharmacol Sci 13 1992 434 439
19. K.E. Thummel, G.R. Wilkinson In vitro and in vivo drug interactions involving human CYP3A Annu Rev Pharmacol Toxicol 38 1998 389 430
20. M.F. Hebert, T.R. Easterling, B. Kirby Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study Clin Pharmacol Ther 84 2008 248 253
21. T.S. Tracy, R. Venkataramanan, D.D. Glover, S.N. Caritis Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy Am J Obstet Gynecol 192 2005 633 639
22. P. Smit, R.H. van Schaik, M. van der Werf A common polymorphism in the CYP3A7 gene is associated with a nearly 50% reduction in serum dehydroepiandrosterone sulfate levels J Clin Endocrinol Metab 90 2005 5313 5316
23. J.S. Leeder, R. Gaedigk, K.A. Marcucci Variability of CYP3A7 expression in human fetal liver J Pharmacol Exp Ther 314 2005 626 635
24. G.M. Kalabis, S. Petropoulos, W. Gibb, S.G. Matthews Multidrug resistance phosphoglycoprotein (ABCB1) expression in the guinea pig placenta: developmental changes and regulation by betamethasone Can J Physiol Pharmacol 87 2009 973 978
25. G.D. Leschziner, T. Andrew, M. Pirmohamed, M.R. Johnson ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research Pharmacogenomics J 7 2006 154 179
26. E.F. van Rossum, E.L. van den Akker Glucocorticoid resistance Endocr Dev 20 2011 127 136
27. K.G. Tantisira, K.M. Small, A.A. Litonjua, S.T. Weiss, S.B. Liggett Molecular properties and pharmacogenetics of a polymorphism of adenylyl cyclase type 9 in asthma: interaction between beta-agonist and corticosteroid pathways Hum Mol Genet 14 2005 1671 1677
28. A.H. Jobe, R.F. Soll Choice and dose of corticosteroid for antenatal treatments Am J Obstet Gynecol 190 2004 878 881
29. D.M. Haas, W. McCullough, C.H. Olsen Neonatal outcomes with different betamethasone dosing regimens: a comparison J Reprod Med 50 2005 915 922
30. P.L. Ballard, P. Granberg, R.A. Ballard Glucocorticoid levels in maternal and cord serum after prenatal betamethasone therapy to prevent respiratory distress syndrome J Clin Invest 56 1975 1548 1554
31. M.F. Hebert, X. Ma, S.B. Naraharisetti Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice Clin Pharmacol Ther 85 2009 607 614